Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Long-Term Investments of $263000.0 for Q4 2025, down 98.24% year-on-year from $15.0 million in Q4 2024, and down 98.24% on a QoQ basis from $15.0 million in Q4 2024.

Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Long-Term Investments for 7 consecutive years, with $263000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments fell 98.24% year-over-year to $263000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $263000.0 (down 98.24% YoY) and the FY2025 annual result came in at $263000.0, down 98.24% from the prior year.
  • Long-Term Investments retreated to $263000.0 in Q4 2025 per CURLF's latest filing, from $15.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for CURLF reached as high as $4.1 billion in Q1 2022 and fell as low as $263000.0 in Q4 2025.
  • A 5-year average of $282.5 million and a median of $7.4 million in 2021 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2022 — Long-Term Investments soared 25164.39% — and 2025, when it slumped 98.24%.
  • Year by year, Long-Term Investments stood at $4.4 million in 2021, then sank by 36.45% to $2.8 million in 2022, then soared by 438.01% to $15.0 million in 2023, then retreated by 0.44% to $15.0 million in 2024, then sank by 98.24% to $263000.0 in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $263000.0, $15.0 million, and $17.1 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.32 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 702.35 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 263,000.00
Dec 31, 2024 14.98 Mn
Sep 30, 2024 17.14 Mn
Jun 30, 2024 13.93 Mn
Dec 31, 2023 15.05 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 2.34 Mn
Dec 31, 2022 2.80 Mn
Sep 30, 2022 3.37 Mn
Jun 30, 2022 3.65 Mn
Mar 31, 2022 4.11 Bn
Dec 31, 2021 4.40 Mn
Sep 30, 2021 7.37 Mn
Jun 30, 2021 23.49 Mn
Mar 31, 2021 16.26 Mn
Dec 31, 2020 16.26 Mn
Sep 30, 2020 62.81 Mn
Dec 31, 2019 51.21 Mn